Drug Safety Information for GEMFIBROZIL (Gemfibrozil)

Safety-related Labeling Changes for LOPID (GEMFIBROZIL) Rx Drug: FDA Link

Adverse Drug Reactions for GEMFIBROZIL* (Gemfibrozil)

These charts and graphs are based on reports received through the FDA Adverse Event Reporting System (FAERS) program (see below).

Top 20 Adverse Effects Associated with GEMFIBROZIL
(reported in FDA Medwatch/FAERS Reports)

  Side Effect # of FDA Reports
1Nausea*544
2Rhabdomyolysis516
3Fatigue*411
4Dyspnoea410
5Dizziness408
6Pain397
7Renal failure acute396
8Asthenia380
9Drug ineffective372
10Diarrhoea*370
11Myocardial infarction359
12Vomiting330
13Myalgia*304
14Diabetes mellitus300
15Chest pain296
16Headache*289
17Pain in extremity284
18Blood glucose increased279
19Drug interaction277
20Cardiac failure congestive274

* This side effect also appears in "Top 10 Side Effects of GEMFIBROZIL " in the drug's Review Summary based on AskaPatient reviews.

Top 10 Reasons for Taking GEMFIBROZIL
(associated with FDA Medwatch/FAERS Reports)

Reason # of FDA Reports
1Product used for unknown indication2913
2Blood cholesterol increased*2266
3Hyperlipidaemia*1569
4Blood triglycerides increased1158
5Blood cholesterol971
6Hypertriglyceridaemia746
7Hypercholesterolaemia614
8Blood triglycerides*358
9Blood cholesterol abnormal334
10Ill-defined disorder325

*Also a top-10 reason in AskaPatient Review Summary.


Types of Adverse Events for GEMFIBROZIL

Total Reports Filed with FDA: 44436


Number of FDA Adverse Event Reports by Patient Age for GEMFIBROZIL

Total Reports Filed with FDA: 44436*


* Reports for drugs with the same active ingredients have been aggregated in this analysis: Gemfibrozil (Lopid, Ausgem, Trialmin, Lipur, Gemcor, Gemfibrozil, Jezil)

Charts are based on 44436 reports filed with the FDA between 2004 and June 2015.

Adverse Event Reports are submitted to the FDA by pharmaceutical companies (mandatory reporting is required by manufacturers, distributors, or importers), health care providers such as doctors (voluntary reporting), and by patients themselves (voluntary reporting). More Information on FDA MedWatch (FDA Safety Information and Adverse Event Reporting Program)Voluntary reporting takes place under the FDA's MedWatch program, where health care professionals and consumers submit reports to FDA when they find a problem with a drug, medical device, biologic, or other FDA-regulated product. An adverse event is any undesirable experience or extreme side effect associated with the use of a medical product. Adverse events include: death, life threatening event, hospitalization, disability or permanent damage, congenital anomaly or birth defect, medical product use requiring a surgical or other intervention, or other serious medical situation believed to be caused by the drug.

Click to go back to search results and GEMFIBROZIL Reviews and Review Summary .

Historical Analytics of FDA Adverse Event Reports Provided by Druginformer.com. FDA Drug Safety Information, including safety-related labeling updates, required post-approval safety studies, risk evaluation management strategies (REMS), alerts, and recalls are compiled by AskaPatient.com from the U.S. Food and Drug Administration.